FTC Hearing On IP Policy: Patent Eligibility Requirements Are Top Industry Concern

Supreme Court decisions on subject matter patentability have discouraged investments, panelists tell FTC; BIO says biotech companies may look outside patent system.

WASHINGTON, DC - MAY 4: Federal Trade Commission Headquarters in downtown Washington, DC on May 4, 2015.

When the US Federal Trade Commission asked a panel of industry representatives for their "patent policy wish list" one answer stood out: a desire for legislation to overrule Supreme Court decisions and expand what inventions are eligible to be patented.

FTC posed the question during an Oct. 23-24 hearing on innovation and intellectual policy. It is among a series of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet